AAAAAA

   
Results: 1-10 |
Results: 10

Authors: MCFARLAND LV ELMER GW
Citation: Lv. Mcfarland et Gw. Elmer, PHARMACEUTICAL PROBIOTICS FOR THE TREATMENT OF ANAEROBIC AND OTHER INFECTIONS, Anaerobe, 3(2-3), 1997, pp. 73-78

Authors: FEKETY R MCFARLAND LV SURAWICZ CM GREENBERG RN ELMER GW MULLIGAN ME
Citation: R. Fekety et al., RECURRENT CLOSTRIDIUM-DIFFICILE DIARRHEA - CHARACTERISTICS OF AND RISK-FACTORS FOR PATIENTS ENROLLED IN A PROSPECTIVE, RANDOMIZED, DOUBLE-BLINDED TRIAL, Clinical infectious diseases, 24(3), 1997, pp. 324-333

Authors: ELMER GW SURAWICZ CM MCFARLAND LV
Citation: Gw. Elmer et al., BIOTHERAPEUTIC AGENTS - A NEGLECTED MODALITY FOR THE TREATMENT AND PREVENTION OF SELECTED INTESTINAL AND VAGINAL INFECTIONS, JAMA, the journal of the American Medical Association, 275(11), 1996, pp. 870-876

Authors: MARTIN SW ELMER GW VEGA R MCFARLAND LV LEVY RH
Citation: Sw. Martin et al., PHARMACOKINETICS OF SACCHAROMYCES-BOULARDII WITHIN THE GASTROINTESTINAL-TRACT LUMEN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 88-88

Authors: MCFARLAND LV BAUWENS JE MELCHER SA SURAWICZ CM GREENBERG RN ELMER GW
Citation: Lv. Mcfarland et al., CIPROFLOXACIN-ASSOCIATED CLOSTRIDIUM-DIFFICILE DISEASE, Lancet, 346(8980), 1995, pp. 977-978

Authors: MCFARLAND LV SURAWICZ CM GREENBERG RN ELMER GW MOYER KA MELCHER SA BOWEN KE COX JL
Citation: Lv. Mcfarland et al., PREVENTION OF BETA-LACTAM-ASSOCIATED DIARRHEA BY SACCHAROMYCES-BOULARDII COMPARED WITH PLACEBO, The American journal of gastroenterology, 90(3), 1995, pp. 439-448

Authors: MCFARLAND LV SURAWICZ CM GREENBERG RN FEKETY R ELMER GW MOYER KA MELCHER SA BOWEN KE COX JL NOORANI Z HARRINGTON G RUBIN M GREENWALD D
Citation: Lv. Mcfarland et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SACCHAROMYCES-BOULARDII IN COMBINATION WITH STANDARD ANTIBIOTICS FOR CLOSTRIDIUM-DIFFICILE DISEASE, JAMA, the journal of the American Medical Association, 271(24), 1994, pp. 1913-1918

Authors: KLEIN SM ELMER GW MCFARLAND LV SURAWICZ CM LEVY RH
Citation: Sm. Klein et al., RECOVERY AND ELIMINATION OF THE BIOTHERAPEUTIC AGENT, SACCHAROMYCES-BOULARDII, IN HEALTHY-HUMAN VOLUNTEERS, Pharmaceutical research, 10(11), 1993, pp. 1615-1619

Authors: SURAWICZ CM GREENBERG RN FEKETY R MCFARLAND LV MOYER K BOWEN K COX J NOORANI Z ELMER GW
Citation: Cm. Surawicz et al., SACCHAROMYCES-BOULARDII PREVENTS RECURRENT CLOSTRIDIUM-DIFFICILE PSEUDOMEMBRANOUS COLITIS AND DIARRHEA - A MULTICENTER CONTROLLED TRIAL, Gastroenterology, 104(4), 1993, pp. 786-786

Authors: MCFARLAND LV SURAWICZ CM ELMER GW MOYER KA MELCHER SA GREENBERG R BOWEN K
Citation: Lv. Mcfarland et al., MULTIVARIATE-ANALYSIS OF THE CLINICAL EFFICACY OF A BIOTHERAPEUTIC AGENT, SACCHAROMYCES-BOULARDII, FOR THE PREVENTION OF ANTIBIOTIC-ASSOCIATED DIARRHEA, American journal of epidemiology, 138(8), 1993, pp. 649-649
Risultati: 1-10 |